Evidence map›Paper›PMID 30467811›Full record

ArticleJournal of neuro-oncology2019

Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life.

Andrew M Heitzer, Jason M Ashford, Camden Hastings, Anthony P Y Liu, Shengjie Wu, Johnnie K Bass, Robert Vestal, Mary Hoehn, Jason Chiang, Yahya Ghazwani and 6 more

Abstract read
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Cognitive Risk in Survivors of Pediatric Brain Tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Andrew M HeitzerDepartment of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA.
Jason M AshfordDepartment of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA.
Camden HastingsPediatric Oncology Education Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
Anthony P Y LiuDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Shengjie WuDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Johnnie K BassRehabilitation Services, St. Jude Children's Research Hospital, Memphis, TN, USA.
Robert VestalDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, USA.
Mary HoehnDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jason ChiangDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yahya GhazwaniDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sahaja AcharyaDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Frederick BoopDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA.
Amar GajjarDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Thomas E MerchantDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ibrahim QaddoumiDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Heather M ConklinDepartment of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. heather.conklin@stjude.org.
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
National Cancer Institute P30-CA21765National Cancer Institute R25CA23944NCI NIH HHS P30 CA021765NCI NIH HHS R25 CA023944
6 · The paper itself

Abstract

purposeLow-grade gliomas (LGG) are a heterogeneous group of brain tumors, which are often assumed to have a benign course. Yet, children diagnosed and treated for LGG in infancy are at increased risk for neurodevelopmental disruption. We sought to investigate neuropsychological outcomes of infants diagnosed with LGG.

methodsBetween 1986 and 2013, 51 patients were diagnosed with LGG before 12 months of age and managed at St. Jude Children's Research Hospital. Twenty-five of the 51 patients received a cognitive assessment (68% male; 6.8 ± 3.3 months at diagnosis; 10.5 ± 4.8 years at latest assessment). Approximately half the patients received radiation therapy (n = 12; aged 4.0 ± 3.0 years at radiation therapy), with a median of 2 chemotherapy regimens (range = 0-5) and 1 tumor directed surgery (range = 0-5).

resultsThe analyses revealed performance below age expectations on measures of IQ, memory, reading, mathematics, and fine motor functioning as well as parent-report of attention, executive, and adaptive functioning. Following correction for multiple comparisons, a greater number of chemotherapy regimens was associated with lower scores on measures of IQ and mathematics. More tumor directed surgeries and presence of visual field loss were associated with poorer dominant hand fine motor control. Radiation therapy exposure was not associated with decline in neuropsychological performance.

conclusionsChildren diagnosed with LGG in infancy experience substantial neuropsychological deficits. Treatment factors, including number of chemotherapy regimens and tumor directed surgeries, may increase risk for neurodevelopmental disruption and need to be considered in treatment planning.

Indexed as

Antineoplastic AgentsBrain NeoplasmsChild, PreschoolCognitive DysfunctionCranial IrradiationFemaleGliomaHumansInfantMaleNeuropsychological TestsPostoperative ComplicationsRisk FactorsTreatment OutcomeAntineoplastic AgentsBrain tumorCancerInfancyLow-grade gliomaNeuropsychological

Identifiers

PMID30467811
PMCPMC6344293
OpenAlexW2901409836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.